NM
Nandkishore Maheshwari
About Nandkishore Maheshwari
Data last updated:
Nandkishore Maheshwari is a Director at Savorite Pharmaceuticals Private Limited (since 2019), Designated Partner at Mypher Pharmaceuticals Llp (since 2014) and Director at Ronald Pharmaceuticals Private Limited (since 2012), and holds 1 more current directorship. The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹178 Cr; the largest is Savorite Pharmaceuticals Private Limited at ₹114 Cr (FY 2025). Earlier, Nandkishore Maheshwari was a Director at Bennet Pharmaceuticals Limited (2003–2012) and Director at Dallas Formulations Private Limited (2006–2018) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Savorite Pharmaceuticals Private Limited U33125GJ2019PTC105923 | Director | 07 Jan 2019 | 2019 | ₹114 Cr (FY 2025) | Active |
 Mypher Pharmaceuticals Llp AAC-7995 | Designated Partner | 10 Oct 2014 | 2014 | ₹33.75 Cr (FY 2024) | Active |
 Ronald Pharmaceuticals Private Limited U24110GJ1993PTC019347 | Director | 20 Jul 2012 | 1993 | ₹30.33 Cr (FY 2024) | Active |
| Avoure Pharma & Healthcare Private Limited U21001GJ2026PTC181507 | Non- Individual Subscriber | 29 Jul 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bennet Pharmaceuticals Limited U24231GJ2003PLC043204 | Director | 20 Nov 2003 | 2003 | ₹75.82 Cr (FY 2025) | Active |
 Dallas Formulations Private Limited U24233MP2000PTC014476 | Director | 16 Jan 2006 | 2000 | ₹10.53 Cr (FY 2025) | Active |
 Medoz Pharmaceuticals Private Limited U24231GJ2000PTC037288 | Director | 03 Jan 2005 | 2000 | ₹13.36 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nandkishore Maheshwari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vedant Nandkishore Maheshwari | 00637223 | Savorite Pharmaceuticals Private Limited , Mypher Pharmaceuticals Llp and 2 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nandkishore Maheshwari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nandkishore Maheshwari
Nandkishore Maheshwari currently holds 4 directorships: Savorite Pharmaceuticals Private Limited (Director, since 07 Jan 2019, revenue ₹114 Cr (FY 2025)); Mypher Pharmaceuticals Llp (Designated Partner, since 10 Oct 2014, revenue ₹33.75 Cr (FY 2024)); Ronald Pharmaceuticals Private Limited (Director, since 20 Jul 2012, revenue ₹30.33 Cr (FY 2024)); Avoure Pharma & Healthcare Private Limited (Non- Individual Subscriber, since 29 Jul 2026).
Nandkishore Maheshwari was first appointed on 20 Nov 2003 as Director at Bennet Pharmaceuticals Limited. The most recent appointment on record is 29 Jul 2026 at Avoure Pharma & Healthcare Private Limited.
The 3 current companies of Nandkishore Maheshwari that report revenue have a combined latest revenue of ₹178 Cr: Savorite Pharmaceuticals Private Limited ₹114 Cr (FY 2025); Mypher Pharmaceuticals Llp ₹33.75 Cr (FY 2024); Ronald Pharmaceuticals Private Limited ₹30.33 Cr (FY 2024).
Nandkishore Maheshwari held 3 earlier board appointments: Bennet Pharmaceuticals Limited (Director, 20 Nov 2003 to 01 Aug 2012); Dallas Formulations Private Limited (Director, 16 Jan 2006 to 04 Oct 2018); Medoz Pharmaceuticals Private Limited (Director, 03 Jan 2005 to 10 Apr 2019).
The current boards of Nandkishore Maheshwari's companies include Vedant Nandkishore Maheshwari (Savorite Pharmaceuticals Private Limited).